These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28973027)

  • 21. Relationship of antibiotic resistance phenotype to the R-pyocin susceptibility pattern in clinical isolates of Pseudomonas aeruginosa.
    Tzouvelekis LS; Tumah H; Malliara K; Legakis NJ
    J Chemother; 1989 Aug; 1(4):226-30. PubMed ID: 2509643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyocin-sensitivity testing as a method of typing Pseudomonas aeruginosa: use of "phage-free" preparations of pyocin.
    Rampling A; Whitby JL; Wildy P
    J Med Microbiol; 1975 Nov; 8(4):531-41. PubMed ID: 812999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Phenotypic relations with regard to pyocin sensitivity, of 191 strains of Pseudomonas aeruginosa isolated in a hospital environment].
    Santini G; Targa S; Basaglia M; Marchetti G; Crovatto M
    Boll Ist Sieroter Milan; 1983 Jul; 62(3):242-6. PubMed ID: 6416270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study of Pseudomonas aeruginosa in relation to pyocine typing drug sensitivity and epidemiology.
    Mohanty SK; Bhuyan BK; Nathsarma KC; Nanda BK
    Indian J Pathol Microbiol; 1982 Jan; 25(1):45-9. PubMed ID: 6809612
    [No Abstract]   [Full Text] [Related]  

  • 25. Pyocin sensitivity of pseudomonas aeruginosa pretreated with antibiotics.
    Stevens GS; Ottolenghi AC
    Can J Microbiol; 1977 May; 23(5):583-8. PubMed ID: 194663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pyocin typing of Pseudomonas aeruginosa strains].
    Moroz AF; Petropavlovskaia IS; Osokina TI; Frolova VV
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jan; (1):31-5. PubMed ID: 6422681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative study on R-type pyocins of Pseudomonas aeruginosa.
    Ohsumi M; Shinomiya T; Kageyama M
    J Biochem; 1980 Apr; 87(4):1119-25. PubMed ID: 6771248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retargeting R-type pyocins to generate novel bactericidal protein complexes.
    Williams SR; Gebhart D; Martin DW; Scholl D
    Appl Environ Microbiol; 2008 Jun; 74(12):3868-76. PubMed ID: 18441117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pore-forming pyocin S5 utilizes the FptA ferripyochelin receptor to kill Pseudomonas aeruginosa.
    Elfarash A; Dingemans J; Ye L; Hassan AA; Craggs M; Reimmann C; Thomas MS; Cornelis P
    Microbiology (Reading); 2014 Feb; 160(Pt 2):261-269. PubMed ID: 24217175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical properties of a new flexuous bacteriocin, pyocin F1, produced by Pseudomonas aeruginosa.
    Kuroda K; Kageyama M
    J Biochem; 1979 Jan; 85(1):7-19. PubMed ID: 104991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the amylovorin locus of Lactobacillus amylovorus DCE 471, producer of a bacteriocin active against Pseudomonas aeruginosa, in combination with colistin and pyocins.
    Moreno MR; Baert B; Denayer S; Cornelis P; De Vuyst L
    FEMS Microbiol Lett; 2008 Sep; 286(2):199-206. PubMed ID: 18803001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibacterial efficacy of R-type pyocins towards Pseudomonas aeruginosa in a murine peritonitis model.
    Scholl D; Martin DW
    Antimicrob Agents Chemother; 2008 May; 52(5):1647-52. PubMed ID: 18332164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lysocins: Bioengineered Antimicrobials That Deliver Lysins across the Outer Membrane of Gram-Negative Bacteria.
    Heselpoth RD; Euler CW; Schuch R; Fischetti VA
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study of 32 new phage tail-like bacteriocins (pyocins) from a clinical collection of Pseudomonas aeruginosa and of their potential use as typing markers and antimicrobial agents.
    Blasco L; de Aledo MG; Ortiz-Cartagena C; Blériot I; Pacios O; López M; Fernández-García L; Barrio-Pujante A; Hernández-Garcia M; Cantón R; Tomás M
    Sci Rep; 2023 Jan; 13(1):117. PubMed ID: 36596850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of R-pyocin activity against Gram-positive pathogens for the first time with special focus on Staphylococcus aureus.
    Mohamed AA; Elshawadfy AM; Amin G; Askora A
    J Appl Microbiol; 2021 Dec; 131(6):2780-2792. PubMed ID: 33977611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyocin efficacy in a murine model of Pseudomonas aeruginosa sepsis.
    Six A; Mosbahi K; Barge M; Kleanthous C; Evans T; Walker D
    J Antimicrob Chemother; 2021 Aug; 76(9):2317-2324. PubMed ID: 34142136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipopolysaccharide as shield and receptor for R-pyocin-mediated killing in Pseudomonas aeruginosa.
    Köhler T; Donner V; van Delden C
    J Bacteriol; 2010 Apr; 192(7):1921-8. PubMed ID: 20118263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of Neisseria gonorrhoeae by a bacteriocin from Pseudomonas aeruginosa.
    Morse SA; Vaughan P; Johnson D; Iglewski BH
    Antimicrob Agents Chemother; 1976 Aug; 10(2):354-62. PubMed ID: 825024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SOS-Independent Pyocin Production in P. aeruginosa Is Induced by XerC Recombinase Deficiency.
    Baggett NS; Bronson AS; Cabeen MT
    mBio; 2021 Dec; 12(6):e0289321. PubMed ID: 34809462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of iron concentration in the growth medium on the sensitivity of Pseudomonas aeruginosa to pyocin S2.
    Ohkawa I; Shiga S; Kageyama M
    J Biochem; 1980 Jan; 87(1):323-31. PubMed ID: 6766926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.